DYANAVEL XR
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
24478-109 -
Package NDC
24478-109-01 -
Application number
NDA210526 -
SPL ID
32c90701-fe4a-4d5a-b3bb-e9ccf0416ece -
SPL set ID
ae304b29-0b40-40ec-ad0d-76b742d4a9b9 -
UNII
CK833KGX7E -
RxCUI
1720586 -
RxCUI
1720592 -
RxCUI
2585460 -
RxCUI
2585461 -
RxCUI
2585462 -
RxCUI
2585465 -
RxCUI
2585468 -
RxCUI
2585471 -
RxCUI
2585473 -
RxCUI
2585476
What the source publishes
- Labeler
- NextWave Pharmaceuticals, Inc
- Active ingredients
- amphetamine
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "DYANAVEL XR",
"splId": "32c90701-fe4a-4d5a-b3bb-e9ccf0416ece",
"labels": [
{
"setId": "ae304b29-0b40-40ec-ad0d-76b742d4a9b9",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae304b29-0b40-40ec-ad0d-76b742d4a9b9",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ae304b29-0b40-40ec-ad0d-76b742d4a9b9"
}
],
"routes": [
"ORAL"
],
"labeler": "NextWave Pharmaceuticals, Inc",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (24478-109-01)",
"package_ndc": "24478-109-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20220801"
}
],
"productId": "24478-109_32c90701-fe4a-4d5a-b3bb-e9ccf0416ece",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "24478-109",
"deaSchedule": "CII",
"genericName": "amphetamine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "AMPHETAMINE",
"strength": "15 mg/1"
}
],
"applicationNumber": "NDA210526",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20211104",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175739",
"N0000175729"
],
"upc": [
"0324478102029",
"0324478108014",
"0324478110017",
"0324478109011"
],
"unii": [
"CK833KGX7E"
],
"rxcui": [
"1720586",
"1720592",
"2585460",
"2585461",
"2585462",
"2585465",
"2585468",
"2585471",
"2585473",
"2585476"
],
"spl_set_id": [
"ae304b29-0b40-40ec-ad0d-76b742d4a9b9"
],
"pharm_class_pe": [
"Central Nervous System Stimulation [PE]"
],
"pharm_class_epc": [
"Central Nervous System Stimulant [EPC]"
],
"manufacturer_name": [
"NextWave Pharmaceuticals, Inc"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:24478-109_32c90701-fe4a-4d5a-b3bb-e9ccf0416ece"